Alicia A Walf Selected Research

2,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)

1/2010	Infusions of anti-sense oligonucleotides for DARPP-32 to the ventral tegmental area reduce effects of progesterone- and a dopamine type 1-like receptor agonist to facilitate lordosis.
9/2008	Activity of protein kinase C is important for 3alpha,5alpha-THP's actions at dopamine type 1-like and/or GABAA receptors in the ventral tegmental area for lordosis of rats.
9/2008	In the ventral tegmental area, progestogens' membrane-mediated actions for lordosis of rats involve the second-messenger phospholipase C.
9/2006	Progestins' effects on sexual behaviour of female rats and hamsters involving D1 and GABA(A) receptors in the ventral tegmental area may be G-protein-dependent.
8/2006	In the ventral tegmental area, progestins have actions at D1 receptors for lordosis of hamsters and rats that involve GABA A receptors.
1/2006	In the ventral tegmental area, progestins' membrane-mediated actions for lordosis of hamsters and rats involve protein kinase A.
6/2005	Progestin-facilitated lordosis of hamsters may involve dopamine-like type 1 receptors in the ventral tegmental area.
7/2004	Progestins' actions in the VTA to facilitate lordosis involve dopamine-like type 1 and 2 receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alicia A Walf Research Topics

Disease

18	Lordosis 03/2014 - 07/2004
4	Neoplasms (Cancer) 03/2011 - 04/2009
4	Breast Neoplasms (Breast Cancer) 02/2010 - 04/2009
2	Alzheimer Disease (Alzheimer's Disease) 06/2009 - 01/2008
2	Shock 05/2008 - 08/2007
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2018
1	Alopecia (Baldness) 01/2018
1	Anosmia 01/2017
1	Sleep Wake Disorders 01/2017
1	Epilepsy (Aura) 01/2014
1	Carcinogenesis 05/2010
1	Pituitary Neoplasms (Pituitary Adenoma) 05/2010
1	Endocrine Gland Neoplasms (Cancer, Endocrine) 02/2010
1	Depressive Disorder (Melancholia) 06/2006
1	Pain (Aches) 04/2004

Drug/Important Bio-Agent (IBA)

13	Progestins (Progestagens)IBA 03/2014 - 07/2004
12	Progesterone FDA LinkGeneric 03/2014 - 04/2004
10	Dopamine (Intropin)FDA LinkGeneric 01/2010 - 07/2004
8	Estradiol (Delestrogen)FDA LinkGeneric 03/2014 - 07/2004
8	2,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)IBA 01/2010 - 07/2004
6	GABA-A Receptors (GABA(A) Receptor)IBA 10/2008 - 01/2006
5	glutathione-bicarbonate-Ringer solution (BSS plus)FDA LinkGeneric 10/2008 - 01/2006
5	MuscimolIBA 09/2008 - 01/2006
5	gamma-Aminobutyric Acid (GABA)IBA 09/2008 - 08/2006
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2008
3	Progesterone Receptors (Progesterone Receptor)IBA 03/2014 - 10/2008
3	Type C PhospholipasesIBA 10/2008 - 09/2008
3	GTP-Binding Proteins (G-Protein)IBA 10/2008 - 01/2006
2	Pregnanolone (Allopregnanolone)IBA 01/2014 - 09/2008
2	Estrogens (Estrogen)FDA Link 03/2011 - 04/2004
2	CarcinogensIBA 03/2011 - 05/2010
2	Hormones (Hormone)IBA 05/2010 - 01/2010
2	Antisense OligonucleotidesIBA 01/2010 - 01/2008
2	SteroidsIBA 01/2010 - 04/2009
2	NeurosteroidsIBA 01/2010 - 01/2006
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 10/2008 - 08/2006
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 10/2008 - 01/2006
2	Sulpiride (neogama)IBA 06/2005 - 07/2004
2	QuinpiroleIBA 06/2005 - 07/2004
2	SCH 23390IBA 06/2005 - 07/2004
1	Testosterone (Sustanon)FDA Link 01/2018
1	Finasteride (Propecia)FDA LinkGeneric 01/2018
1	Dihydrotestosterone (Androstanolone)IBA 01/2018
1	Amyloid beta-PeptidesIBA 01/2017
1	N,N- di- n- hexyl- 2- (4- fluorophenyl)indole- 3- acetamideIBA 01/2014
1	PK 11195 (PK11195)IBA 01/2014
1	N-Methylaspartate (NMDA)IBA 01/2014
1	9,10-Dimethyl-1,2-benzanthraceneIBA 05/2010
1	Raloxifene Hydrochloride (Evista)FDA Link 05/2010
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2010
1	Peptides (Polypeptides)IBA 02/2010
1	Steroid Receptors (Steroid Receptor)IBA 01/2010
1	Oxytocin Receptors (Oxytocin Receptor)IBA 01/2010
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2010
1	GlobulinsIBA 01/2010
1	Oxidoreductases (Dehydrogenase)IBA 08/2009
1	trilostane FDA Link 08/2009
1	Estrogen ReceptorsIBA 08/2009
1	Tamoxifen FDA LinkGeneric 08/2009
1	bisindolylmaleimideIBA 09/2008
1	Protein Kinase CIBA 09/2008
1	1- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dioneIBA 09/2008
1	Conjugated (USP) Estrogens (Premarin)FDA Link 05/2008
1	Amyloid (Amyloid Fibrils)IBA 01/2008
1	Estrogen Receptor betaIBA 01/2008
1	Estrogen Receptor alphaIBA 01/2008
1	Protein Isoforms (Isoforms)IBA 01/2008
1	Presenilin-1IBA 01/2008
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 09/2006
1	guanosine 5'-O-(2-thiodiphosphate)IBA 09/2006
1	bis(p-chlorophenyl)acetic acid (DDA)IBA 08/2006
1	EnzymesIBA 08/2006
1	Pharmaceutical PreparationsIBA 08/2006
1	BicucullineIBA 08/2006
1	Adenosine (Adenocard)FDA LinkGeneric 01/2006
1	protein kinase modulatorIBA 01/2006
1	betadex (beta-cyclodextrin)IBA 01/2006
1	Mifepristone (RU 486)FDA Link 07/2004

Therapy/Procedure

2	Therapeutics 02/2010 - 04/2009
1	Injections 01/2010
1	Cannula 07/2004